Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
View All Featured ArticlesHeadline News
Health Canada authorizes Moderna’s mRNA flu and combination flu-COVID vaccines
FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy
Petosemtamab combination cuts risk of death by 50% in Phase III head and neck cancer trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Just in Time Release of CAR T Cell Therapies
Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
11th November 2019
Continuous Capture and Continuous Recovery – Novel Ideas for Product Recovery from Perfusion Process Using ATF
Presented by Dr. Kerstin Lange, Team Lead Process Technology and Innovation, Advanced Bioprocessing, Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech and Earl Pineda Sr. Manager, Upstream Field Applications EU/APAC at Repligen
03rd February 2021
Establishing Early Development Strategies For Therapeutics Proteins
Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Strategy Emerging Markets for Risk Mitigation
Column Packing Protocol for Amsphere A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
